Autonomous driving paper index
Triboelectric nanogenerators for cancer prevention and therapy: a new paradigm in cancer management
One-line summary
Cancer remains a leading global cause of mortality despite significant advances in surgery, chemotherapy, radiotherapy, targeted therapy, and immunotherapy.
Engineering notes
Key topics: autonomous driving. See the paper for implementation details and experimental results.
Chinese explanation / 中文解读
中文解读待补充：本站会优先为端到端自动驾驶、BEV感知、3D目标检测、轨迹预测、路径规划、LiDAR感知等高价值论文补充中文说明。
Original abstract
Cancer remains a leading global cause of mortality despite significant advances in surgery, chemotherapy, radiotherapy, targeted therapy, and immunotherapy. However, limitations such as systemic toxicity, poor specificity, drug resistance, and inadequate early detection continue to hinder effective management. Recently, triboelectric nanogenerators (TENGs) which convert biomechanical and environmental mechanical energy into electrical energy have emerged as promising self-powered platforms for biomedical applications. Owing to their high-voltage, low-current output, flexibility, lightweight structure, and biocompatibility, TENGs offer unique opportunities in cancer prevention, diagnosis, therapy, drug delivery, and immunotherapy. Collectively, TENG technology represents a paradigm shift toward sustainable, self-powered cancer management platforms that integrate prevention, therapy, and immunomodulation into a unified framework. This review consolidates the theoretical foundations, operating modes, and mechanistic advantages of TENGs, highlighting their translational potential in oncology including detection of carcinogens, adjuvant therapy, drug and gene delivery, and immunotherapy while also addressing current limitations and future directions.
Links and sources
Need this topic turned into a technical roadmap?
Full Self Driving can prepare a custom autonomous driving literature review, code map, dataset map, and B2B technology assessment.
Request B2B research
Comments